Medtronic Gets FDA OK for Inceptiv Closed-Loop Spinal Cord Stimulator

Dow Jones04-26

By Colin Kellaher

Medtronic has won Food and Drug Administration approval of its Inceptiv closed-loop rechargeable spinal cord stimulator, or SCS, to treat chronic pain.

Medtronic on Friday said Inceptiv is its first SCS device to offer a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time.

The Dublin-based company said Inceptiv adjusts for movements such as laughing, bending or sneezing that can result in brief moments of uncomfortable overstimulation from traditional fixed-output SCS devices, which in turn may lead some patients to turn down their device's stimulation output.

Medtronic plans to initiate the U.S. market launch of Inceptiv, which was previously approved for sale in Europe and Japan, in the coming weeks.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

April 26, 2024 08:41 ET (12:41 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2430327921?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-04-26 20:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2430327921","market":"fut","top_or_hot":-1,"title":"Medtronic Gets FDA OK for Inceptiv Closed-Loop Spinal Cord Stimulator","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre>\n \n</pre>\n<p>\n  Medtronic has won Food and Drug Administration approval of its Inceptiv closed-loop rechargeable spinal cord stimulator, or SCS, to treat chronic pain. \n</p>\n<p>\n  Medtronic on Friday said Inceptiv is its first SCS device to offer a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time. \n</p>\n<p>\n  The Dublin-based company said Inceptiv adjusts for movements such as laughing, bending or sneezing that can result in brief moments of uncomfortable overstimulation from traditional fixed-output SCS devices, which in turn may lead some patients to turn down their device's stimulation output. \n</p>\n<p>\n  Medtronic plans to initiate the U.S. market launch of Inceptiv, which was previously approved for sale in Europe and Japan, in the coming weeks. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 26, 2024 08:41 ET (12:41 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Medtronic Gets FDA OK for Inceptiv Closed-Loop Spinal Cord Stimulator</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMedtronic Gets FDA OK for Inceptiv Closed-Loop Spinal Cord Stimulator\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-26 20:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>By Colin Kellaher \n\n\n \n\n\n  Medtronic has won Food and Drug Administration approval of its Inceptiv closed-loop rechargeable spinal cord stimulator, or SCS, to treat chronic pain. \n\n\n  Medtronic on ...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1989771016.USD","symbol_name":"东方汇理环球老龄化投资基金 A2 Acc","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2430327921","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2430327921","pubTimestamp":1714135260,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Medtronic has won Food and Drug Administration approval of its Inceptiv closed-loop rechargeable spinal cord stimulator, or SCS, to treat chronic pain.Medtronic on Friday said Inceptiv is its first SCS device to offer a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time.The Dublin-based company said Inceptiv adjusts for movements such as laughing, bending or sneezing that can result in brief moments of uncomfortable overstimulation from traditional fixed-output SCS devices, which in turn may lead some patients to turn down their device's stimulation output.Medtronic plans to initiate the U.S. market launch of Inceptiv, which was previously approved for sale in Europe and Japan, in the coming weeks.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","LU2023251221.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (USD) INC","BK4082":"医疗保健设备","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","LU2089284900.SGD":"Allianz Global Sustainability Cl AM Dis H2-SGD","LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","BK4588":"碎股","LU1989764748.USD":"东方汇理环球颠覆性机遇A2 Acc","BK4585":"ETF&股票定投概念","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","LU0496365809.HKD":"TEMPLETON GLOBAL INCOME \"A\" (HKD) INC (Q)","LU0211326755.USD":"TEMPLETON GLOBAL INCOME \"A\" (USD) ACC","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","LU0158827948.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"A\" (USD) INC","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","LU2089283258.USD":"安联环球可持续基金Cl AM Dis","LU0976567544.SGD":"FTIF - Templeton Global Income A Mdis SGD-H1","LU0211326839.USD":"TEMPLETON GLOBAL INCOME \"A\" (USD) INC","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","MDT":"美敦力"},"translate_title":"美敦力Inceptiv闭环脊髓刺激器获得FDA批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MDT":0.9},"content_text":"By Colin Kellaher \n\n\n \n\n\n  Medtronic has won Food and Drug Administration approval of its Inceptiv closed-loop rechargeable spinal cord stimulator, or SCS, to treat chronic pain. \n\n\n  Medtronic on Friday said Inceptiv is its first SCS device to offer a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time. \n\n\n  The Dublin-based company said Inceptiv adjusts for movements such as laughing, bending or sneezing that can result in brief moments of uncomfortable overstimulation from traditional fixed-output SCS devices, which in turn may lead some patients to turn down their device's stimulation output. \n\n\n  Medtronic plans to initiate the U.S. market launch of Inceptiv, which was previously approved for sale in Europe and Japan, in the coming weeks. \n\n\n \n\n\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 26, 2024 08:41 ET (12:41 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2430327921"}